The Department of Urology at Peking Union Medical College Hospital was established in the 1940s. In the 1950s, pioneering medical figures such as Yu Songting, Wu Jieping, and Shi Xien developed it into a specialized department of considerable scale. From the 1960s to the 1980s, experts like Liu Guozhen, Wu Decheng, and Xia Mofu further advanced it into a nationally renowned urology specialty. Motivated by the hospital's motto of 'rigor, precision, diligence, and dedication,' the department has evolved over decades into a top-tier institution specializing in adrenal surgery, minimally invasive urology, kidney transplantation, urological male reproductive tumors, urinary stones, general urology, and andrology.
The department currently has three wards with a total of 110 beds (92 in general wards and 18 in special wards). It is equipped with advanced and comprehensive diagnostic, laboratory, and treatment facilities, capable of performing various clinical examinations and treatments. In addition to multiple laparoscopic surgical devices, 3D laparoscopic equipment, robotic laparoscopic surgical systems, and integrated imaging operating rooms, it possesses top-tier cystoscopy imaging equipment, rigid and flexible ureteroscopes, percutaneous nephroscopes, 2um and 1.9um lasers, holmium lasers, EMS lithotripters, extracorporeal shock wave lithotripters, ultrasound diagnostic devices, imaging urodynamic diagnostic devices, prostate cancer brachytherapy devices, sexual function diagnostic devices, biofeedback therapy devices, and advanced endourological diagnostic and treatment equipment. The department admits over 4,000 inpatients annually, performing approximately 3,900 surgeries, with complex and challenging surgeries accounting for about one-third. The outpatient volume exceeds 120,000 visits per year, with 4,500 outpatient surgeries (including cystoscopy). To facilitate patient care, the outpatient department includes subspecialty clinics for andrology, stones, tumors, and adrenal surgery.
The department currently has 35 physicians, 32 nurses, and 3 technicians. Among them are 9 chief physicians, 10 associate chief physicians, 12 attending physicians, 3 resident physicians, and 10 graduate students. The department includes a standing committee member of the Urology Branch of the Chinese Medical Association, a vice-chairman of the Urology Branch of the Beijing Medical Association, a vice-president of the Andrology Physician Branch of the Chinese Physician Association, a president of the Andrology Physician Branch of the Beijing Physician Association, a chairman of the Urology Expert Committee of the Beijing Medical Award Foundation, a vice-chairman of the Urological Oncology Professional Committee of the Beijing Oncology Society, and several other committee members; one editorial board member of the Chinese Journal of Urology, one editorial board member of the Chinese Journal of Surgery, one deputy editor of the Chinese Journal of Andrology, and editorial board members of several other professional journals.
The department undertakes the urology teaching responsibilities for Peking Union Medical College and serves as a standardized training base for resident physicians in Beijing, as well as a clinical postdoctoral research station, having trained numerous outstanding resident physicians and postdoctoral fellows. As a training base for grassroots medical institutions nationwide, it receives urology physicians from across the country for short-term training in rational drug use (LEAP) each year. It is one of the earliest authorized doctoral degree-granting points for urology by the State Council Academic Degrees Committee, currently having 6 doctoral supervisors and 5 master's supervisors. In recent years, it has trained over 30 doctoral and master's students. The department enrolls 6-8 doctoral and master's degree students annually and currently has 10 in-service graduate students.
As a clinical key specialty of the Ministry of Health, the department hosts multiple national conferences each year. It has received one Ministry of Health Science and Technology Progress Award, one Chinese Medical Science and Technology Award, one Huaxia Medical Award, and over 20 awards for research and medical achievements from educational institutions, along with a national Science and Technology Progress Award in collaboration with other departments. It has multiple research projects funded by the National Natural Science Foundation and others. The department emphasizes academic standards, encourages research design and publication of academic papers, and publishes over thirty articles in domestic core journals and SCI journals annually. It has obtained 5 national invention patents.
On February 22, 2017, Liu Yandong, a member of the Political Bureau of the CPC Central Committee and Vice Premier of the State Council, visited Peking Union Medical College Hospital for research. Vice Premier Liu Yandong, along with Li Bin, Director of the National Health and Family Planning Commission, visited the urology ward, where Liu Yandong learned in detail about the hospital's medical services, quality management, cost control, and cultural construction, fully affirming the hospital's philosophy of 'treating patients like family and treating colleagues like kin' and recognizing the hospital's experiences in medical services, quality safety management, medical research, talent cultivation, medical support, and rational drug use.
Currently, the Department of Urology is a vibrant, united, and proactive team that has shown remarkable development momentum in recent years. The hospital will continue to expand its advantageous projects, innovate within the framework of overall hospital development, continuously improve medical technology and service quality, promote clinical and basic research in urology, and cultivate more professional talents, making significant contributions to the medical field in China.
Century-Old Heritage · Premier Specialties
Foundational unit for adrenal surgery in China. Led by renowned experts such as Professor Li Hanzhong, the department has set a national benchmark for perioperative management and minimally invasive surgery in complex adrenal surgeries, including pheochromocytoma, primary hyperaldosteronism, and Cushing's syndrome, achieving extremely low mortality rates. The department has widely adopted Da Vinci robotic and laparoscopic techniques.
Established a close multidisciplinary team (MDT) for adrenal diseases in collaboration with the Endocrinology and Anesthesiology departments, extensively utilizing Da Vinci surgical robots and 3D laparoscopy, aiming for tumor eradication and maximal organ function preservation.
Da Vinci robotic-assisted and retroperitoneoscopic resection of complex large pheochromocytomas and adrenal tumors, with leading perioperative hemodynamic stability control in the country
Robot-assisted laparoscopic nephron-sparing tumor excision (zero ischemia/extremely short ischemia time)
Robot-assisted laparoscopic radical prostatectomy (nerve-sparing and urinary control preservation) and radical cystectomy with orthotopic ileal neobladder
Minimally invasive percutaneous nephrolithotomy (PCNL) and flexible ureteroscopic holmium laser lithotripsy (RIRS)
Transurethral laser prostatectomy for benign prostatic hyperplasia (HoLEP) and minimally invasive hydrodynamic enucleation
Chief Physician, Professor, Doctoral Supervisor
Core Indications & Conditions Treated
Master of Chinese adrenal and urological surgery. Renowned internationally for surgical safety and outcomes in giant pheochromocytoma and adrenal tumors.
Chief Physician, Professor, Doctoral Supervisor
Core Indications & Conditions Treated
Chair of Urology at PUMCH, expert in da Vinci robotic surgery for adrenal masses, nerve-sparing radical prostatectomy, and partial nephrectomy.
Chief Physician, Professor, Doctoral Supervisor
Core Indications & Conditions Treated
Specializes in laparoscopic radical surgery for urologic malignancies, complex pheochromocytoma, and multiple endocrine neoplasia.
Chief Physician, Professor
Core Indications & Conditions Treated
Expert in minimally invasive endourology, PCNL, flexible ureteroscopic laser lithotripsy, and laser enucleation of the prostate (HoLEP).
Chief Physician, Professor, Doctoral Supervisor
Core Indications & Conditions Treated
Specializes in MRI-ultrasound fusion targeted prostate biopsy, laparoscopic nerve-sparing radical prostatectomy, and partial nephrectomy.
Attending Physician
Core Indications & Conditions Treated
Dr. Li Yongqiang is an Attending Physician in urology, focusing on targeted therapy for renal cell carcinoma and urolithiasis.
Chief Physician, Professor, Doctoral Supervisor
Core Indications & Conditions Treated
Dr. Shi Bingbing is a chief physician and professor with over 20 years of clinical experience in urology, focusing on urological tumors, adrenal diseases, and urolithiasis.
Chief Physician, Professor
Core Indications & Conditions Treated
Dr. Liu Guanghua is a chief physician and professor specializing in the management of various urological tumors and laparoscopic surgery for urological conditions.
Chief Physician, Associate Professor
Core Indications & Conditions Treated
Dr. Xiao He is a chief physician and associate professor with extensive experience in minimally invasive stone treatment and the management of ureteral strictures and urinary tract stones.
Chief Physician, Professor
Core Indications & Conditions Treated
Dr. Zhang Ruiqiang is a chief physician and professor with a focus on urological tumors, including bladder and prostate cancers.
Chief Physician, Associate Professor
Core Indications & Conditions Treated
Dr. Fan Xinrong is a chief physician and associate professor specializing in the diagnosis and treatment of various urological tumors, including bladder cancer and renal cell carcinoma.
Chief Physician, Professor
Core Indications & Conditions Treated
Dr. Zang Meifu is a chief physician and professor with expertise in male urology and complex diseases affecting female urology, particularly concerning the kidney, bladder, and ureter.
Chief Physician, Professor
Core Indications & Conditions Treated
Dr. Li Hongjun is a chief physician and professor specializing in male reproductive health, including infertility and chronic prostatitis.
Chief Physician, Professor
Core Indications & Conditions Treated
Dr. Xie Yi is a Chief Physician and Professor in Urology, specializing in urological tumors and renal cancers, with significant experience in kidney transplantation and minimally invasive surgical techniques.
Associate Chief Physician, Associate Professor
Core Indications & Conditions Treated
Dr. Huang Zhongming is an Associate Chief Physician and Associate Professor specializing in urological and male reproductive tumors.
Associate Chief Physician, Associate Professor
Core Indications & Conditions Treated
Dr. Yan Su is an Associate Chief Physician and Associate Professor in Urology, specializing in sexual dysfunction and related disorders. He has a deep understanding of male reproductive health and has conducted extensive research in this field.
Associate Chief Physician
Core Indications & Conditions Treated
Dr. Wang Hai is an Associate Chief Physician in Urology, specializing in the surgical treatment of premature ejaculation, male infertility, and varicocele.
Attending Physician
Core Indications & Conditions Treated
Dr. Zhang Yinsheng is an Attending Physician in Urology, specializing in common urological diseases and complex male reproductive tumors.
Chief Physician, Professor
Dr. Wen Jin is a Chief Physician and Professor in Urology, with expertise in minimally invasive and robotic surgery for urological tumors and stones.
Attending Physician
Core Indications & Conditions Treated
Dr. Huang Houfeng is an Attending Physician in Urology, specializing in bladder and prostate cancer, and comprehensive treatment of renal tumors.
Chief Physician, Professor
Core Indications & Conditions Treated
Dr. Zhang Yushi is a Chief Physician and Professor in Urology, with expertise in the diagnosis and treatment of urinary system tumors and laparoscopic techniques.
Associate Chief Physician
Core Indications & Conditions Treated
Dr. Zhou Yi is an Associate Chief Physician specializing in urology, with expertise in early diagnosis and minimally invasive treatment of prostate tumors, including transperineal saturation biopsy and image-guided targeted biopsy.
Associate Chief Physician
Core Indications & Conditions Treated
Dr. Zhou Jingmin is an Associate Chief Physician specializing in urological tumors, including bladder, renal, and prostate tumors.
Chief Physician, Professor
Core Indications & Conditions Treated
Dr. Xu Weifeng is a Chief Physician and Professor specializing in renal cell carcinoma, bladder cancer, prostate cancer, and minimally invasive surgery for urological tumors.
Chief Physician, Associate Professor
Core Indications & Conditions Treated
Dr. Deng Jianhua is a chief physician and associate professor specializing in urological cancers, with a focus on adrenal and renal tumors.
Associate Chief Physician
Core Indications & Conditions Treated
Dr. Wu Xingcheng is an associate chief physician specializing in urological diseases, particularly adrenal diseases.
Chief Physician, Associate Professor
Core Indications & Conditions Treated
Dr. Zhang Xuebin is a Chief Physician and Associate Professor specializing in urogenital tumors, including bladder and prostate cancers, with extensive clinical experience in minimally invasive surgical techniques.
Associate Chief Physician
Core Indications & Conditions Treated
Dr. Fan Hua is an Associate Chief Physician in the Department of Urology, proficient in the diagnosis and surgical treatment of urological tumors, including adrenal and renal tumors.
Associate Chief Physician, Associate Professor
Core Indications & Conditions Treated
Dr. Dong Dexin is an Associate Chief Physician and Associate Professor specializing in renal surgery and urological tumors, with expertise in minimally invasive techniques.
Associate Chief Physician, Associate Professor
Core Indications & Conditions Treated
Dr. Zhou Zhien is an Associate Chief Physician and Associate Professor in the Department of Urology, focusing on the diagnosis and treatment of common urological diseases, including prostate cancer.
Attending Physician, Lecturer
Core Indications & Conditions Treated
Dr. Wang Dong is an Attending Physician and Lecturer in Urology, specializing in the comprehensive diagnosis and treatment of adrenal diseases and nephron-sparing treatments for benign renal tumors.
Attending Physician
Core Indications & Conditions Treated
Dr. Qiao Yi is an attending physician in urology, specializing in the diagnosis and treatment of common urological diseases, with a focus on surgical treatment of urolithiasis and metabolic assessment.
Attending Physician
Core Indications & Conditions Treated
Dr. Ye Zixing is an attending physician in urology, proficient in managing urological tumors, calculi, adrenal surgical diseases, and benign prostatic hyperplasia.
Associate Chief Physician
Core Indications & Conditions Treated
Dr. Ma Lin is an associate chief physician in urology, specializing in urinary tract infections and functional urological disorders.
Attending Physician
Core Indications & Conditions Treated
Dr. Zhao Xin is an attending physician in urology, specializing in the diagnosis and treatment of common urological diseases, urinary tract infections, adrenal diseases, and renal tumors.
Attending Physician
Core Indications & Conditions Treated
Dr. Lian Penggu is an Attending Physician in Urology, specializing in bladder cancer, adrenal surgery, and the diagnosis and treatment of benign prostatic hyperplasia.
Associate Chief Physician, Associate Professor
Core Indications & Conditions Treated
Dr. Dong Jie is an Associate Chief Physician and Associate Professor in Urology, focusing on common diseases of the urinary system, adrenal tumors, and renal cell carcinoma.
Attending Physician
Core Indications & Conditions Treated
Dr. Wang Wenda is an Attending Physician in the Department of Urology, specializing in the diagnosis and treatment of common urological diseases.
Attending Physician
Core Indications & Conditions Treated
Dr. Zuo Yuzhi is an Attending Physician in the Department of Urology, specializing in common urological diseases.
Attending Physician
Core Indications & Conditions Treated
Dr. Zhao Yi is an attending physician in urology, focusing on renal neoplasms, renal cysts, adrenal tumors, and bladder tumors. He has extensive experience in urological surgery and has been practicing at Peking Union Medical College Hospital since 2015.
Attending Physician
Core Indications & Conditions Treated
Zheng Guoyang is an Attending Physician in the Urology Department, focusing on Adrenal Diseases and minimally invasive treatment of urological tumors. He is an active member of the American Urological Association and has published extensively.
Resident Physician
Core Indications & Conditions Treated
Wei Mengchao is a Resident Physician in the Urology Department, specializing in Common Urological Diseases. He has a strong research background and has published multiple articles in peer-reviewed journals.
Independent support for patients seeking care at PUMCH
Century-Old Heritage · Premier Specialties
